Procrit Critical Care Label Expansion Could Fuel Franchise Sales, J&J Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Johnson & Johnson remains committed to the anemia agent despite failing to return the franchise to growth in 2005.